# Circular Genomics and PharmatrophiX Announce Strategic Collaboration to Advance circRNA Biomarkers in Neurodegenerative Drug Development

- Source: PR Newswire M&A
- Published: 2026-11-04T13:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/circular-genomics-and-pharmatrophix-announce-strategic-collaboration-to-advance-circrna-biomarkers-in-neurodegenerative-drug-development-302927460.html
- Canonical: https://groundlevelnews.com/story/circular-genomics-and-pharmatrophix-announce-strategic-collaboration-t-d526b0/

Collaboration will initially apply blood-based circular RNA profiling to LM11A-31 in Alzheimer's disease, with potential expansion across PharmatrophiX's neurodegeneration pipeline SAN DIEGO and MENLO PARK, Calif., Nov. 4, 2026 /PRNewswire/ -- Circular Genomics, Inc., a precision...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._